Business Description
Allarity Therapeutics is a Boston-based pharmaceutical company founded in 2004 that works to match cancer patients with treatments most likely to work for them. The company uses its own proprietary technology to predict how individual patients will respond to specific drugs, helping to guide more targeted treatment decisions. Its primary focus is Stenoparib, a cancer-fighting drug currently in a Phase 2 trial for women with advanced or recurring ovarian cancer, alongside a paired diagnostic tool designed to identify which patients are best suited for the treatment.
